Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IVA - Inventiva - ADR


Previous close
2.39
0   0%

Share volume: 5,526
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$2.39
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
24%
Profitability 25%
Dept financing 8%
Liquidity 73%
Performance 15%
Company vs Stock growth
vs
Performance
5 Days
-5.63%
1 Month
-3.62%
3 Months
-36.38%
6 Months
-37.08%
1 Year
-37.43%
2 Year
-49.67%
Key data
Stock price
$2.39
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.09 - $4.75
52 WEEK CHANGE
-$0.38
MARKET CAP 
118.861 M
YIELD 
N/A
SHARES OUTSTANDING 
52.477 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
09/25/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,309
AVERAGE 30 VOLUME 
$4,948
Company detail
CEO: Frederic Cren
Region: US
Website: http://inventivapharma.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news